Citations (18)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Charlotte A. Espensen, Ane L. Appelt, Lotte S. Fog, Juliette Thariat, Anita B. Gothelf, Marianne C. Aznar & Jens F. Kiilgaard. (2020) Tumour control probability after Ruthenium-106 brachytherapy for choroidal melanomas. Acta Oncologica 59:8, pages 918-925.
Read now
Read now
Articles from other publishers (17)
Yu-Hsuan Tseng, Chia-An Hsu & Yu-Bai Chou. (2024) Comparing efficacy of charged-particle therapy with brachytherapy in treatment of uveal melanoma. Eye.
Crossref
Crossref
Vera E. Pawlik, Svenja R. Sonntag, Salvatore Grisanti, Aysegül Tura, Vinodh Kakkassery & Mahdy Ranjbar. (2024) Impact of Nintedanib and Anti-Angiogenic Agents on Uveal Melanoma Cell Behavior. Investigative Opthalmology & Visual Science 65:2, pages 30.
Crossref
Crossref
Hilal Nalcı Baytaroğlu, Ahmet Kaan Gündüz, Ibadulla Mirzayev & Funda Seher Özalp Ateş. (2023) Factors affecting eye conservation and metastasis in posterior uveal melanomas. European Journal of Ophthalmology 33:5, pages 2024-2033.
Crossref
Crossref
Roderick F. J. O’Day, Kelsey A. Roelofs, Guy S. Negretti, Gordon Hay, Amit K. Arora, Ian Stoker, Bertil E. Damato, Mandeep S. Sagoo & Victoria M. L. Cohen. (2022) Long-term visual outcomes after ruthenium plaque brachytherapy for posterior choroidal melanoma. Eye 37:5, pages 959-965.
Crossref
Crossref
Francesca Buonanno, Manuel Conson, Cintia de Almeida Ribeiro, Caterina Oliviero, Francesca Itta, Raffaele Liuzzi, Roberto Pacelli, Laura Cella & Stefania Clemente. (2022) Local tumor control and treatment related toxicity after plaque brachytherapy for uveal melanoma: A systematic review and a data pooled analysis. Radiotherapy and Oncology 166, pages 15-25.
Crossref
Crossref
Renato Jose Yupari, James Bena, Allan Wilkinson, John Suh & Arun Singh. (2021) Small choroidal melanoma: outcomes following apical height dose brachytherapy. British Journal of Ophthalmology 105:8, pages 1161-1165.
Crossref
Crossref
Charlotte A. Espensen, Ane L. Appelt, Lotte S. Fog, Anita B. Gothelf, Juliette Thariat & Jens F. Kiilgaard. (2019) Predicting Visual Acuity Deterioration and Radiation-Induced Toxicities after Brachytherapy for Choroidal Melanomas. Cancers 11:8, pages 1124.
Crossref
Crossref
Sati Akbaba, Robert Foerster, Nils Henrik Nicolay, Nathalie Arians, Tilman Bostel, Juergen Debus & Henrik Hauswald. (2018) Linear accelerator-based stereotactic fractionated photon radiotherapy as an eye-conserving treatment for uveal melanoma. Radiation Oncology 13:1.
Crossref
Crossref
Jon B. Hansen, Wesley S. Culberson & Larry A. DeWerd. (2018) Windowless extrapolation chamber measurement of surface dose rate from a 90 Sr/ 90 Y ophthalmic applicator. Radiation Measurements 108, pages 34-40.
Crossref
Crossref
Marina Marinkovic, Nanda Horeweg, Marta Fiocco, Femke P. Peters, Linda W. Sommers, Mirjam S. Laman, Jaco C. Bleeker, Martijn Ketelaars, Gre P.M. Luyten & Carien L. Creutzberg. (2016) Ruthenium-106 brachytherapy for choroidal melanoma without transpupillary thermotherapy: Similar efficacy with improved visual outcome. European Journal of Cancer 68, pages 106-113.
Crossref
Crossref
Andrew W. Browne, Savita V. Dandapani, Richard Jennelle, Marta Stevanovic, Thomas C. Lee, A. Linn Murphree, Thomas D. Kampp, Melvin A. Astrahan, Jonathan W. Kim & Jesse L. Berry. (2015) Outcomes of medium choroidal melanomas treated with ruthenium brachytherapy guided by three-dimensional pretreatment modeling. Brachytherapy 14:5, pages 718-725.
Crossref
Crossref
Alex Lebeau. 2015. Hamilton & Hardy's Industrial Toxicology. Hamilton & Hardy's Industrial Toxicology
187
192
.
Daniel Grossi Marconi, Douglas Guedes de Castro, Lievin Matos Rebouças, Gabriel Oliveira Bernardes Gil, Ricardo Cesar Fogaroli, Maria Aparecida Conte Maia, Maria Leticia Gobo Silva, Antonio Cassio Assis Pellizzon & Maria Marta Motono Chojniak. (2013) Tumor control, eye preservation, and visual outcomes of ruthenium plaque brachytherapy for choroidal melanoma. Brachytherapy 12:3, pages 235-239.
Crossref
Crossref
Sou‐Tung Chiu‐Tsao, Melvin A. Astrahan, Paul T. Finger, David S. Followill, Ali S. Meigooni, Christopher S. Melhus, Firas Mourtada, Mary E. Napolitano, Ravinder Nath, Mark J. Rivard, D. W. O. Rogers & Rowan M. Thomson. (2012)
Dosimetry of
125
I and
103
Pd COMS eye plaques for intraocular tumors: Report of Task Group 129 by the AAPM and ABS
. Medical Physics 39:10, pages 6161-6184.
Crossref
Crossref
Andrey A. Yarovoy, Dzhavid A. Magaramov & Evgeniya S. Bulgakova. (2012) The comparison of ruthenium brachytherapy and simultaneous transpupillary thermotherapy of choroidal melanoma with brachytherapy alone. Brachytherapy 11:3, pages 224-229.
Crossref
Crossref
Alena Furdova, Peter Strmen, Iveta Waczulikova, Martin Chorvath, Miron Sramka & Peter Slezak. (2018) One-Day Session LINAC–Based Stereotactic Radiosurgery of Posterior Uveal Melanoma. European Journal of Ophthalmology 22:2, pages 226-235.
Crossref
Crossref
Karijn M.S. Verschueren, Carien L. Creutzberg, Nicoline E. Schalij-Delfos, Martijn Ketelaars, Floor L.L. Klijsen, Barbara I. Haeseker, Sabine M.B. Ligtenberg, Jan E.E. Keunen & Corrie A.M. Marijnen. (2010) Long-term outcomes of eye-conserving treatment with Ruthenium106 brachytherapy for choroidal melanoma. Radiotherapy and Oncology 95:3, pages 332-338.
Crossref
Crossref